T1	PROC 44 203	ENSAYO CLINICO FASE IV-II, DE COMPROBACIÓN, DISTRIBUIDO AL AZAR, CONTROLADO Y ENMASCARADO CON TRATAMIENTO FINGIDO, EN DOS GRUPOS, REALIZADO EN UN SOLO HOSPITAL
T2	PROC 210 238	EVALUAR EFICACIA Y SEGURIDAD
T3	CHEM 257 268	MEDICAMENTO
#1	AnnotatorNotes T3	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T4	PROC 281 299	PINCHAZO EN EL OJO
T5	ANAT 296 299	OJO
#2	AnnotatorNotes T5	C0015392; Eye; Body Part, Organ, or Organ Component | C1280202; Entire eye; Body Part, Organ, or Organ Component
T6	DISO 349 388	DEGENERACION MACULAR ASOCIADA A LA EDAD
#3	AnnotatorNotes T6	C0242383; Age related macular degeneration; Disease or Syndrome
T7	PROC 411 576	ENSAYO CLÍNICO DE FASE IV-II, PRUEBA DE CONCEPTO, ALEATORIZADO, CONTROLADO CON TRATAMIENTO FINGIDO, CON DOBLE-ENMASCARAMIENTO Y UNICÉNTRICO, CON DOS GRUPOS PARALELOS
T8	PROC 583 617	EVALUAR LA EFICACIA Y LA SEGURIDAD
#4	AnnotatorNotes T8	C0511730; Identify product efficacy and safety issues; Health Care Activity
T9	CHEM 654 664	ETAMSILATO
#5	AnnotatorNotes T9	C0014968; ethamsylate; Organic Chemical · Pharmacologic Substance
T10	DISO 717 756	DEGENERACIÓN MACULAR ASOCIADA A LA EDAD
#6	AnnotatorNotes T10	C0242383; Age related macular degeneration; Disease or Syndrome
T11	DISO 779 818	Degeneración macular asociada a la edad
#7	AnnotatorNotes T11	C0242383; Age related macular degeneration; Disease or Syndrome
T12	DISO 844 883	Degeneración macular asociada a la edad
#8	AnnotatorNotes T12	C0242383; Age related macular degeneration; Disease or Syndrome
T13	DISO 885 889	DMAE
#9	AnnotatorNotes T13	C0242383; Age related macular degeneration; Disease or Syndrome
T14	DISO 985 1006	DMAE seca o exudativa
#10	AnnotatorNotes T14	C3888461; Dry age-related macular degeneration; Anatomical Abnormality | C0271084; Exudative age-related macular degeneration; Disease or Syndrome
T15	PROC 1008 1021	diagnosticada
#11	AnnotatorNotes T15	C0011900; Diagnosis; Diagnostic Procedure
T16	PROC 1095 1125	mejor agudeza visual corregida
#12	AnnotatorNotes T16	C1275680; Corrected visual acuity; Diagnostic Procedure
T17	PROC 1237 1246	protocolo
#13	AnnotatorNotes T17	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T18	PROC 1277 1301	consentimiento informado
#14	AnnotatorNotes T18	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T19	DISO 1344 1348	DMAE
#15	AnnotatorNotes T19	C0242383; Age related macular degeneration; Disease or Syndrome
T20	ANAT 1404 1410	ocular
#16	AnnotatorNotes T20	C0015392; Eye; Body Part, Organ, or Organ Component | C1280202; Entire eye; Body Part, Organ, or Organ Component
T21	PROC 1486 1496	valoración
#17	AnnotatorNotes T21	C1261322; Evaluation procedure; Health Care Activity
T22	DISO 1503 1507	DMAE
#18	AnnotatorNotes T22	C0242383; Age related macular degeneration; Disease or Syndrome
T23	DISO 1514 1522	glaucoma
#19	AnnotatorNotes T23	C0017601; Glaucoma; Disease or Syndrome
T24	DISO 1524 1580	daños estructurales permanentes en el centro de la fóvea
T25	ANAT 1575 1580	fóvea
#20	AnnotatorNotes T25	C0016622; Structure of fovea centralis; Body Part, Organ, or Organ Component | C0450290; Entire fovea centralis; Body Part, Organ, or Organ Component
T26	DISO 1582 1613	atrofia geográfica parafoveolar
T27	DISO 1615 1647	vasculopatía coroidea polipoidal
#21	AnnotatorNotes T27	C1504336; Polypoidal choroidal vasculopathy; Disease or Syndrome
T28	ANAT 1628 1636	coroidea
#22	AnnotatorNotes T28	C0008520; Choroid; Body Part, Organ, or Organ Component | C1305287; Entire choroid; Body Part, Organ, or Organ Component
T29	DISO 1670 1696	enfermedades concomitantes
#23	AnnotatorNotes T29	C0243087; concomitant disease; Pathologic Function
T30	DISO 1751 1761	enfermedad
#24	AnnotatorNotes T30	C0012634; Disease; Disease or Syndrome
T31	PROC 1776 1788	tratamientos
#25	AnnotatorNotes T31	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T32	PROC 1820 1830	valoración
#26	AnnotatorNotes T32	C1261322; Evaluation procedure; Health Care Activity
T33	DISO 1837 1841	DMAE
#27	AnnotatorNotes T33	C0242383; Age related macular degeneration; Disease or Syndrome
T34	DISO 1848 1865	diabetes mellitus
#28	AnnotatorNotes T34	C0011849; Diabetes Mellitus; Disease or Syndrome | C1802373; Diabetes mellitus (incl subtypes); Disease or Syndrome
T35	ANAT 1881 1887	ocular
#29	AnnotatorNotes T35	C0015392; Eye; Body Part, Organ, or Organ Component | C1280202; Entire eye; Body Part, Organ, or Organ Component
T36	DISO 1889 1908	infección sistémica
#30	AnnotatorNotes T36	C0243026; Sepsis; Disease or Syndrome
T37	DISO 1938 1954	infección ocular
T38	DISO 1956 1980	trastornos psiquiátricos
#31	AnnotatorNotes T38	C0004936; Mental disorders; Mental or Behavioral Dysfunction
T39	PROC 2106 2117	tratamiento
#32	AnnotatorNotes T39	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T40	PROC 624 650	ADMINISTRACIÓN INTRAVÍTREA
T41	DISO 1394 1410	patología ocular
T42	DISO 1870 1887	afectación ocular
T43	ANAT 1948 1954	ocular
#33	AnnotatorNotes T43	C0015392; Eye; Body Part, Organ, or Organ Component | C1280202; Entire eye; Body Part, Organ, or Organ Component
T44	CHEM 2128 2145	fármaco anti-VEGF
T45	Date 12 16	2014
T47	LIVB 335 344	PACIENTES
#34	AnnotatorNotes T47	C0030705; Patients; Patient or Disabled Group
T48	Route 639 650	INTRAVÍTREA
#35	AnnotatorNotes T48	C1517572; Intravitreal Route of Drug Administration; Functional Concept
T49	ANAT 792 799	macular
#36	AnnotatorNotes T49	C0450295; Retinal macula; Body Part, Organ, or Organ Component | C1284755; Entire macula lutea; Body Part, Organ, or Organ Component
T50	LIVB 703 712	PACIENTES
#37	AnnotatorNotes T50	C0030705; Patients; Patient or Disabled Group
T51	LIVB 919 936	Pacientes adultos
#38	AnnotatorNotes T51	C0030705; Patients; Patient or Disabled Group + C0001675; Adult; Age Group
T52	LIVB 956 967	ambos sexos
#39	AnnotatorNotes T52	C0025266; Male population group; Population Group + C0043210; Woman; Population Group
T53	Age 938 951	18 años o más
T54	LIVB 971 980	Pacientes
#40	AnnotatorNotes T54	C0030705; Patients; Patient or Disabled Group
T55	Duration 1044 1064	los dos años previos
T56	LIVB 1067 1076	Pacientes
#41	AnnotatorNotes T56	C0030705; Patients; Patient or Disabled Group
T57	DEVI 1169 1183	optotipo ETDRS
#42	AnnotatorNotes T57	C1275992; ETDRS visual acuity chart; Medical Device
T58	LIVB 1187 1196	Pacientes
#43	AnnotatorNotes T58	C0030705; Patients; Patient or Disabled Group
T60	LIVB 1330 1339	Pacientes
#44	AnnotatorNotes T60	C0030705; Patients; Patient or Disabled Group
T61	LIVB 1363 1372	Pacientes
#45	AnnotatorNotes T61	C0030705; Patients; Patient or Disabled Group
T62	LIVB 1429 1441	investigador
#46	AnnotatorNotes T62	C0035173; Research Personnel; Professional or Occupational Group
T64	LIVB 1656 1665	Pacientes
#47	AnnotatorNotes T64	C0030705; Patients; Patient or Disabled Group
T65	LIVB 1715 1727	investigador
#48	AnnotatorNotes T65	C0035173; Research Personnel; Professional or Occupational Group
T67	Date 1909 1917	en curso
T69	LIVB 2077 2086	Pacientes
#49	AnnotatorNotes T69	C0030705; Patients; Patient or Disabled Group
T70	Route 2146 2157	intravítreo
T71	Duration 2161 2180	los últimos 3 meses
T72	LIVB 2184 2229	Mujeres embarazadas o en periodo de lactancia
#50	AnnotatorNotes T72	C0033011; Pregnant Women; Population Group | C4316174; Patients who are breastfeeding; Patient or Disabled Group
T46	ANAT 362 369	MACULAR
#51	AnnotatorNotes T46	C0450295; Retinal macula; Body Part, Organ, or Organ Component | C1284755; Entire macula lutea; Body Part, Organ, or Organ Component
T75	ANAT 857 864	macular
#52	AnnotatorNotes T75	C0450295; Retinal macula; Body Part, Organ, or Organ Component | C1284755; Entire macula lutea; Body Part, Organ, or Organ Component
T76	ANAT 730 737	MACULAR
#53	AnnotatorNotes T76	C0450295; Retinal macula; Body Part, Organ, or Organ Component | C1284755; Entire macula lutea; Body Part, Organ, or Organ Component
T59	PHYS 2220 2229	lactancia
#54	AnnotatorNotes T59	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T63	PHYS 2192 2203	embarazadas
#55	AnnotatorNotes T63	C0032961; Pregnancy; Organism Function
T66	Observation 1982 2037	situaciones sociales que puedan afectar al cumplimiento
A1	Population_data T51 Age
A2	Status T39 History_of
A3	Status T44 History_of
A4	Status T23 History_of
A5	Status T24 History_of
A6	Status T26 History_of
A7	Status T27 History_of
#56	AnnotatorNotes T2	C0511730; Identify product efficacy and safety issues; Health Care Activity
#57	AnnotatorNotes T37	C0015403; Eye Infection; Disease or Syndrome 
#58	AnnotatorNotes T70	C1517572; Intravitreal Route of Drug Administration; Functional Concept
T68	Spec_cue 1442 1447	pueda
T73	CONC 1448 1455	influir
A8	Assertion T73 Speculated
#59	AnnotatorNotes T73	C0521102; Interferes with; Functional Concept
R1	Speculation Arg1:T68 Arg2:T73	
T74	CONC 1735 1742	influir
A9	Assertion T74 Speculated
#60	AnnotatorNotes T74	C0521102; Interferes with; Functional Concept
T77	Spec_cue 1728 1734	puedan
R2	Speculation Arg1:T77 Arg2:T74	
T78	Spec_cue 2007 2013	puedan
T79	CONC 2014 2021	afectar
A10	Assertion T79 Speculated
#61	AnnotatorNotes T79	C0521102; Interferes with; Functional Concept
R3	Speculation Arg1:T78 Arg2:T79	
R4	Location_of Arg1:T5 Arg2:T4	
#62	AnnotatorNotes T4	C2069457; Intravitreal injection of pharmacologic agent; Therapeutic or Preventive Procedure (?)
R5	Used_for Arg1:T9 Arg2:T40	
#63	AnnotatorNotes T40	C2069457; Intravitreal injection of pharmacologic agent; Therapeutic or Preventive Procedure
R6	Has_Route_or_Mode Arg1:T9 Arg2:T48	
R7	Experiences Arg1:T47 Arg2:T3	
R8	Experiences Arg1:T47 Arg2:T4	
R9	Experiences Arg1:T47 Arg2:T6	
R10	Location_of Arg1:T46 Arg2:T6	
R11	Experiences Arg1:T50 Arg2:T40	
R12	Experiences Arg1:T50 Arg2:T10	
R13	Location_of Arg1:T76 Arg2:T10	
R14	Location_of Arg1:T49 Arg2:T11	
R15	Location_of Arg1:T75 Arg2:T12	
R16	Location_of Arg1:T75 Arg2:T13	
R17	Has_Age Arg1:T51 Arg2:T53	
R18	Has_Age Arg1:T52 Arg2:T53	
R19	Experiences Arg1:T54 Arg2:T14	
R20	Overlap Arg1:T15 Arg2:T55	
R21	Overlap Arg1:T14 Arg2:T55	
T80	Result_or_Value 1126 1146	entre 20/25 y 20/320
R22	Has_Result_or_Value Arg1:T16 Arg2:T80	
R23	Used_for Arg1:T57 Arg2:T16	
R24	Experiences Arg1:T56 Arg2:T16	
R25	Before Arg1:T18 Arg2:T17	
T81	Quantifier_or_Qualifier 1352 1360	5º grado
R26	Has_Quantifier_or_Qualifier Arg1:T19 Arg2:T81	
R27	Experiences Arg1:T60 Arg2:T19	
R28	Location_of Arg1:T20 Arg2:T41	
R29	Experiences Arg1:T61 Arg2:T41	
R31	Experiences Arg1:T61 Arg2:T23	
R32	Experiences Arg1:T61 Arg2:T24	
R33	Location_of Arg1:T25 Arg2:T24	
R34	Experiences Arg1:T61 Arg2:T26	
R35	Location_of Arg1:T28 Arg2:T27	
R36	Experiences Arg1:T61 Arg2:T27	
R37	Experiences Arg1:T61 Arg2:T22	
R38	Experiences Arg1:T61 Arg2:T21	
#64	AnnotatorNotes T41	C0015397; Disorder of eye; Disease or Syndrome
R39	Overlap Arg1:T41 Arg2:T22	
R40	Overlap Arg1:T22 Arg2:T23	
R41	Overlap Arg1:T22 Arg2:T24	
R42	Overlap Arg1:T22 Arg2:T26	
R43	Overlap Arg1:T22 Arg2:T27	
R54	Experiences Arg1:T64 Arg2:T29	
R57	Experiences Arg1:T64 Arg2:T30	
R58	Experiences Arg1:T64 Arg2:T31	
R60	Location_of Arg1:T35 Arg2:T42	
R61	Overlap Arg1:T36 Arg2:T67	
T82	Quantifier_or_Qualifier 1920 1926	activa
#65	AnnotatorNotes T82	C0679217; Active State; Idea or Concept
R62	Has_Quantifier_or_Qualifier Arg1:T36 Arg2:T82	
R63	Location_of Arg1:T43 Arg2:T37	
R64	Experiences Arg1:T64 Arg2:T33	
R65	Experiences Arg1:T64 Arg2:T32	
R66	Experiences Arg1:T64 Arg2:T34	
R67	Experiences Arg1:T64 Arg2:T42	
R68	Experiences Arg1:T64 Arg2:T36	
R69	Experiences Arg1:T64 Arg2:T37	
R70	Experiences Arg1:T64 Arg2:T38	
R71	Experiences Arg1:T64 Arg2:T66	
R78	Overlap Arg1:T30 Arg2:T33	
R81	Overlap Arg1:T33 Arg2:T34	
R82	Overlap Arg1:T33 Arg2:T42	
R83	Overlap Arg1:T33 Arg2:T36	
R84	Overlap Arg1:T33 Arg2:T37	
R85	Overlap Arg1:T33 Arg2:T38	
R77	Overlap Arg1:T33 Arg2:T66	
R87	Experiences Arg1:T69 Arg2:T39	
R88	Used_for Arg1:T44 Arg2:T39	
R89	Has_Route_or_Mode Arg1:T44 Arg2:T70	
R90	Has_Duration_or_Interval Arg1:T44 Arg2:T71	
#66	AnnotatorNotes T44	C4759940; Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance); Pharmacologic Substance (?)
R91	Experiences Arg1:T72 Arg2:T59	
R92	Experiences Arg1:T72 Arg2:T63	
T83	Observation 1201 1246	capacidad y voluntad para seguir el protocolo
R95	Used_for Arg1:T3 Arg2:T4	
T84	Observation 671 699	MEJORÍA DE LA AGUDEZA VISUAL
R97	Experiences Arg1:T50 Arg2:T84	
R98	Before Arg1:T40 Arg2:T84	
T85	Observation 306 331	MEJORAR LA AGUDEZA VISUAL
R99	Before Arg1:T3 Arg2:T85	
R100	Experiences Arg1:T47 Arg2:T85	
#67	AnnotatorNotes T42	C0262477; Eye problem; Finding (?)
R30	Overlap Arg1:T29 Arg2:T33	
#68	AnnotatorNotes T67	C0521116; Current (present time); Temporal Concept
A11	Experiencer T47 Patient
A12	Experiencer T50 Patient
A13	Experiencer T51 Patient
A14	Experiencer T52 Patient
A15	Experiencer T54 Patient
A16	Experiencer T58 Patient
A17	Experiencer T56 Patient
A18	Experiencer T60 Patient
A19	Experiencer T61 Patient
A20	Experiencer T62 Other
A21	Experiencer T64 Patient
A22	Experiencer T65 Other
A23	Experiencer T69 Patient
A24	Experiencer T72 Patient
